Leptin and peroxisome proliferator-activated receptor γ expression in colorectal adenoma

World Journal of Gastroenterology

Volumn 18, Issue 6, 2012, Pages 557-562

  Kim, Hyung Hun ^a,b   Kim, You Sun ^a   Kang, Yun Kyung ^a   Moon, Jeong Seop ^a  

^a Inje University College of Medicine   (South Korea)

^b Kosin University College of Medicine   (South Korea)

Author keywords

Body mass index; Colorectal adenoma; Leptin; Obesity; Peroxisome proliferator activated receptor

Indexed keywords

LEPTIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

ADULT; ARTICLE; BODY MASS; CLINICAL ARTICLE; COLORECTAL ADENOMA; CONTROLLED STUDY; DYSPLASIA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PATHOLOGY; PROTEIN EXPRESSION;

EID: 84863038581     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v18.i6.557     Document Type: Article

References (35)

1. Tuynman JB, Vermeulen L, Boon EM, Kemper K, Zwinderman AH, Peppelenbosch MP, Richel DJ. Cyclooxygenase-2 inhibition inhibits c-Met kinase activity and Wnt activity in colon cancer. Cancer Res 2008; 68: 1213-1220
2. Sung JJ, Lau JY, Goh KL, Leung WK. Increasing incidence of colorectal cancer in Asia: implications for screening. Lancet Oncol 2005; 6: 871-876
3. Bianchini F, Kaaks R, Vainio H. Overweight, obesity, and cancer risk. Lancet Oncol 2002; 3: 565-574
4. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 2003; 348: 1625-1638
5. Sinicrope FA, Foster NR, Sargent DJ, O'Connell MJ, Rankin C. Obesity is an independent prognostic variable in colon cancer survivors. Clin Cancer Res 2010; 16: 1884-1893
6. Giovannucci E. Insulin, insulin-like growth factors and colon cancer: a review of the evidence. J Nutr 2001; 131: 3109S-3120S
7. Stattin P, Lukanova A, Biessy C, Söderberg S, Palmqvist R, Kaaks R, Olsson T, Jellum E. Obesity and colon cancer: does leptin provide a link? Int J Cancer 2004; 109: 149-152
8. Attele AS, Shi ZQ, Yuan CS. Leptin, gut, and food intake. Biochem Pharmacol 2002; 63: 1579-1583
9. Hardwick JC, Van Den Brink GR, Offerhaus GJ, Van Deventer SJ, Peppelenbosch MP. Leptin is a growth factor for colonic epithelial cells. Gastroenterology 2001; 121: 79-90
10. Aparicio T, Kotelevets L, Tsocas A, Laigneau JP, Sobhani I, Chastre E, Lehy T. Leptin stimulates the proliferation of human colon cancer cells in vitro but does not promote the growth of colon cancer xenografts in nude mice or intestinal tumorigenesis in Apc(Min/+) mice. Gut 2005; 54: 1136-1145
11. Koda M, Sulkowska M, Kanczuga-Koda L, Surmacz E, Sulkowski S. Overexpression of the obesity hormone leptin in human colorectal cancer. J Clin Pathol 2007; 60: 902-906
12. Paik SS, Jang SM, Jang KS, Lee KH, Choi D, Jang SJ. Leptin expression correlates with favorable clinicopathologic phenotype and better prognosis in colorectal adenocarcinoma. Ann Surg Oncol 2009; 16: 297-303
13. Ok KS, Kim YS, Kim HH, Ryu SH, Lee JH, Moon JS, Kang YK. The difference of clinicopathologic features according to leptin expression in colorectal adenoma. Korean J Gastroenterol 2010; 56: 20-26
14. Tontonoz P, Spiegelman BM. Fat and beyond: the diverse biology of PPARgamma. Annu Rev Biochem 2008; 77: 289-312
15. Thompson EA. PPARgamma physiology and pathology in gastrointestinal epithelial cells. Mol Cells 2007; 24: 167-176
16. Elrod HA, Sun SY. PPARgamma and Apoptosis in Cancer. PPAR Res 2008; 2008: 704165
17. Osawa E, Nakajima A, Wada K, Ishimine S, Fujisawa N, Kawamori T, Matsuhashi N, Kadowaki T, Ochiai M, Sekihara H, Nakagama H. Peroxisome proliferator-activated receptor gamma ligands suppress colon carcinogenesis induced by azoxymethane in mice. Gastroenterology 2003; 124: 361-367
18. Matthiessen MW, Pedersen G, Albrektsen T, Adamsen S, Fleckner J, Brynskov J. Peroxisome proliferator-activated receptor expression and activation in normal human colonic epithelial cells and tubular adenomas. Scand J Gastroenterol 2005; 40: 198-205
19. Han S, Roman J. Peroxisome proliferator-activated receptor gamma: a novel target for cancer therapeutics? Anticancer Drugs 2007; 18: 237-244
20. Ogino S, Shima K, Baba Y, Nosho K, Irahara N, Kure S, Chen L, Toyoda S, Kirkner GJ, Wang YL, Giovannucci EL, Fuchs CS. Colorectal cancer expression of peroxisome proliferator-activated receptor gamma (PPARG, PPARgamma) is associated with good prognosis. Gastroenterology 2009; 136: 1242-1250
21. Ishikawa M, Kitayama J, Nagawa H. Enhanced expression of leptin and leptin receptor (OB-R) in human breast cancer. Clin Cancer Res 2004; 10: 4325-4331
22. Frankenberry KA, Skinner H, Somasundar P, McFadden DW, Vona-Davis LC. Leptin receptor expression and cell signaling in breast cancer. Int J Oncol 2006; 28: 985-993
23. Garofalo C, Koda M, Cascio S, Sulkowska M, Kanczuga-Koda L, Golaszewska J, Russo A, Sulkowski S, Surmacz E. Increased expression of leptin and the leptin receptor as a marker of breast cancer progression: possible role of obesity-related stimuli. Clin Cancer Res 2006; 12: 1447-1453
24. Grosfeld A, Andre J, Hauguel-De Mouzon S, Berra E, Pouyssegur J, Guerre-Millo M. Hypoxia-inducible factor 1 transactivates the human leptin gene promoter. J Biol Chem 2002; 277: 42953-42957
25. Meissner U, Ostreicher I, Allabauer I, Rascher W, Dötsch J. Synergistic effects of hypoxia and insulin are regulated by different transcriptional elements of the human leptin promoter. Biochem Biophys Res Commun 2003; 303: 707-712
26. Wang B, Wood IS, Trayhurn P. Hypoxia induces leptin gene expression and secretion in human preadipocytes: differential effects of hypoxia on adipokine expression by preadipocytes. J Endocrinol 2008; 198: 127-134
27. Ahima RS, Osei SY. Leptin signaling. Physiol Behav 2004; 81: 223-241
28. Bjørbaek C, El-Haschimi K, Frantz JD, Flier JS. The role of SOCS-3 in leptin signaling and leptin resistance. J Biol Chem 1999; 274: 30059-30065
29. Rajasingh J, Bright JJ. 15-Deoxy-delta12,14-prostaglandin J2 regulates leukemia inhibitory factor signaling through JAK-STAT pathway in mouse embryonic stem cells. Exp Cell Res 2006; 312: 2538-2546
30. Chearwae W, Bright JJ. PPARgamma agonists inhibit growth and expansion of CD133+ brain tumour stem cells. Br J Cancer 2008; 99: 2044-2053
31. Dubourdeau M, Chêne G, Coste A, Bernad J, Lepert JC, Orfila C, Pipy B, Rousseau D. Opposite roles of STAT and PPARgamma in the induction of p21WAF1 expression by IL-13 in human peripheral blood monocytes. Eur Cytokine Netw 2008; 19: 156-165
32. Zhou Y, Jia X, Qin J, Lu C, Zhu H, Li X, Han X, Sun X. Leptin inhibits PPARgamma gene expression in hepatic stellate cells in the mouse model of liver damage. Mol Cell Endocrinol 2010; 323: 193-200
33. Kim KY, Kim JY, Sung YY, Jung WH, Kim HY, Park JS, Cheon HG, Rhee SD. Inhibitory effect of leptin on rosiglitazone-induced differentiation of primary adipocytes prepared from TallyHO/Jng mice. Biochem Biophys Res Commun 2011; 406: 584-589
34. Lee JI, Paik YH, Lee KS, Lee JW, Kim YS, Jeong S, Kwon KS, Lee DH, Kim HG, Shin YW, Kim MA. A peroxisome-proliferator activated receptor-gamma ligand could regulate the expression of leptin receptor on human hepatic stellate cells. Histochem Cell Biol 2007; 127: 495-502
35. Han GW, Yoo BW, Cho YJ, Oh JE, Hong SH, Cho CY. The polyps of the attributes and the rate of colon polypectomy, in the elderly over the age of 65. Korean J Clin Geri 2009; 10: 157-165